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Eurycoma longifolia is a Malaysian native herb that has been widely used as an
aphrodisiac and a remedy for andropause. Although the physiological effects of the
plant extract were predicted as a result of the alterations in protein expression, the
key protein(s) involved in these alterations are still unclear. In the present study, we
have investigated the effect of standardized E. longifolia extract on serum protein
expression up to 28 days following oral administration in rats. Serum protein profiles
were analyzed by 2-dimensional electrophoresis, and altered proteins were identified via
mass spectrometry. We observed that alpha-2-HS glycoprotein (AHS) was significantly
decreased in the serum of experimentally treated rats compared to pre-treated
animals. Moreover, reduction in AHS was confirmed using competitive enzyme-linked
immunosorbent assay. AHS expression is known to be associated with insulin resistance
and diabetes. Our data indicated that serum AHS was reduced in rats treated with
standardized E. longifolia extract, and therefore form a prelude for further investigation
into the effects of this natural extract in animal models involving infertility and diabetes.
Keywords: 2-dimensional electrophoresis, alpha-2-HS glycoprotein, Eurycoma longifolia, plant extract, mouse
model
Introduction
Eurycoma longifolia Jack is a tall, slender shrub-tree that is commonly found in the lowland forests
up to 500 m above sea level in Southeast Asia (Kuo et al., 2004). The root of E. longifolia is widely
used in folk medicine as a recuperative tonic after childbirth and for treating fever, boils, wound
ulcers, syphilis, and bleeding gums (Burkill, 1966). It has also been employed as a traditional
remedy for malaria, high blood pressure, fatigue, loss of sexual desire, and impotence (Chan et al.,
1998). Notably, it was demonstrated that eurycomanone, a quassinoid isolated from E. longifolia
roots, displayed cytotoxicity against cancer cells as well as antimalarial and antiulcer activities (Bhat
and Karim, 2010). Furthermore, several studies showed that E. longifolia extracts could improve
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sexual performance (Ang and Sim, 1998; Zanoli et al., 2009) and
sperm quality in rats (Noor et al., 2004; Chan et al., 2009; Wahab
et al., 2010). Clinical studies conﬁrmed that sperm quality and
testosterone levels in infertile males improved upon treatment
with E. longifolia (Tambi and Imran, 2010; Tambi et al., 2012).
We recently provided evidence that eurycomanone
obtained from the standardized extract F2 could improved
spermatogenesis and fertility in rats (Low et al., 2013). The
validated HPLC method for the phytochemical analysis
of the active constituents in the standardized extract F2
was found to contain 34.14% w/w of the major bioactive
quassinoids, comprising 13α(21)-epoxyeurycomanone (1)
(7.39 ± 0.17%, w/w), eurycomanone (2) (14.49 ± 0.26%, w/w),
13,21-dihydroeurycomanone (3) (0.72 ± 0.06%, w/w) and
eurycomanol (4) (9.54 ± 0.22%, w/w) (Figure 1) (Low et al.,
2013). In fact, we observed elevation of testosterone, luteinizing
hormone, and follicle stimulating hormone in plasma, along with
suppression of estrogen, after oral administration of E. longifolia
extract, revealing its eﬀect on the hypothalamic-pituitary-
gonadal axis (Low et al., 2013). This increase in male fertility
and hormones following treatment with the quassinoid-rich
E. longifolia extract suggests that it may alter animal physiology.
However, no study has identiﬁed the protein(s) linking
eurycomanone to its in vivo physiological eﬀects. Although it is
predicted that these physiological changes result from alterations
in protein expression following E. longifolia treatment, it
remains unclear which proteins might be aﬀected (Tsai and
Wiltbank, 1998). Thus, the aim of this study was to investigate
serum proteomic proﬁle changes following administration
of standardized bioactive E. longifolia in an animal model.
E. longifolia-treated male Sprague-Dawley rats were compared
to pre-treated animals over 28 days, and serum proteins were
analyzed using two-dimensional gel electrophoresis (2-DE) and
subsequently identiﬁed via mass spectrometry (MS).
FIGURE 1 | The active ingredients of Eurycoma longifolia F2 extract.
Materials and Methods
Extraction
The standardized E. longifolia extract was prepared and
quassinoid content was determined through a high performance
liquid chromatography (HPLC)-based method as described
previously (Teh et al., 2011; Chan et al., 2012). E. longifolia roots
were purchased from Biotropics Malaysia Berhad, Kuala Lumpur,
Malaysia. A voucher specimen of the plant has been deposited
at Penang Botanical Garden, Malaysia, with a reference no. of
JTB1189 (Low et al., 2013). Brieﬂy, the E. longifolia roots were
ground into a powder, and ∼100 kg were extracted with 10 L of
methanol at 45◦C (8 h per day, replacing fresh solvent for ﬁve
consecutive days). Filtrates of the crude extract were combined
and evaporated to dryness in vacuo. The dried methanolic extract
was subjected to a resin-packed column and gradually eluted with
a MeOH–H2O mixture (1:0–0:1 ratio; Chan et al., 2012). The
quassinoid-containing fraction was identiﬁed as the standardized
E. longifolia extract and was dried before oral administration.
Animals
Six Sprague-Dawley male rats (12 weeks old, weighing 290–
310 g) were obtained from the Animal Research and Service
Centre, University of Science Malaysia, Penang, Malaysia. The
animals were fed with a commercial pellet diet (Gold Coin,
Penang, Malaysia) and the water was provided ad libitum. The
rats were individually caged and housed in a 12 h light-dark
cycle at ambient room temperature. All animal experimentation
was humanely conducted and maintained in accordance with
Guide for the Care and Use of Laboratory Animals 2010
Animal Research and Service Centre, Universiti Sains Malaysia
and European legislation (EEC n. 86/609). The experimental
designs and procedures were approved by the institutional
Animal Ethics Committee with Approval No: USM/Animal
Ethics Approval/2012/(79) (386).
Treatment and Monitoring
Prior to experimentation, the rats were kept for 1 week upon
husbandry in accordance with guidelines set by the European
Agency for the Evaluation of Medicinal Products. Animals were
kept in cages with free access to food and water and were orally
given standardized E. longifolia extract at a dose of 50 mg/kg
for 28 days, consecutively. Blood samples (∼0.15 mL at pre-
treatment and day 1; 0.2 mL at day 7, 14, 21, and 28) were
collected from the tail veins of treated rats in accordance to
the guidelines set by the John Hopkins Medicine Guidelines for
multiple blood draws (John Hopkins Medicine, 2012). Sera were
separated through centrifugation at 3,000 rpm for 15 min and
stored at −20◦C prior to analysis.
Protein Estimation of Serum Samples
The protein concentrations of each samples group (n = 6) were
quantiﬁed using 660 nm Protein Assay kit (Thermoscientiﬁc,
Rockford, IL, USA). The serum samples were diluted in 1:1000
factor and then added into microplate wells (10 μl each). One
hundred ﬁfty micro liter of the protein assay reagent was added
into each well and then incubated for 5 min. The absorbance was
measured using μQuantTM microplate spectrometer.
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Protein Separation Using 2-DE
Six biologically replicates for each treatment (pre-treatment, days
1, 7, 14, 21, and 28) were analyzed by 2-DE (Chen et al., 2008;
Chen et al., 2009; Mu et al., 2012). Brieﬂy, the serum samples
(∼3 μl each) were rehydrated in 11 cm precast Immobilline
Drystrips at pH 4–7 (GE Healthcare Biosciences, Uppsala,
Sweden) for 16 h. The rehydrated strips were subjected to
isoelectric focusing with IPGphor 3 (GE Healthcare Biosciences,
Uppsala, Sweden) for a total duration of 14 kV/h (Phase 1: 500
V, 50 mA, 500 V/h; Phase 2: 1,000 V, 50 mA, 1,000 V/h; Phase
3: 8,000 V, 50 mA, 12.5 V/h). Focused strips were equilibrated
with equilibration buﬀer (1.5 M Tris-HCl, pH8.8; 6 M urea;
2% w/v SDS; 30% v/v glycerol) containing 0.06 M DTT for
15 min. They were further incubated in equilibration buﬀer
containing 4.5% v/v iodoacetamide for 15 min. For the second
dimension, the focused strips were subjected to sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) using 8–
18% gradient gels. According to the optimized protocol (Phase
1: 50 V, 17 mA, 15 W for 30 min; Phase 2: 600 V, 25 mA,
15 W for 2 h), electrophoresis was performed using the SE 600
Ruby Electrophoresis System and Power supply EPS601 (GE
Healthcare, Uppsala, Sweden).
Staining of 2-DE Gels
After 2-DE protein separation, the gels were ﬁxed and silver-
stained according toMortz et al. (2001). For protein identiﬁcation
by tryptic digestion and MS, a modiﬁed silver-staining method
was performed according to Shevchenko et al. (1996).
Analysis of Protein Profiles
The silver-stained gels were scanned using the ImageScanner
III (GE Healthcare Biosciences, Uppsala, Sweden). The Image
Master Platinum 7.0 software (GE Healthcare Biosciences,
Uppsala, Sweden) was used to evaluate the 2-DE proﬁles of serum
samples obtained from all the six rats pre-treated and treated with
E. longifolia. The percentage volume contribution of protein spots
was calculated (i.e., the spot volume of a protein expressed as a
percentage of the total spot volume of all detected proteins).
Statistical Analysis
All values were expressed as mean ± SD. The Student’s t-test was
used to compare the experimental groups with regard to mean
percentage volume contribution for the detected spots. Student’s
t-test was also used to compare the mean percentage inhibition
of AHS following the treatment at various intervals compared
to that of pre-treatment. A p-value of <0.05 was considered
signiﬁcant.
Protein Identification Using MALDI TOF/TOF
For MALDI-TOF-MS, the gels plugs containing proteins of
interest from the 2-DE gels were subjected to in-gel digestion
based on the manufacturer’s instruction (Pierce, Rockford, IL,
USA). The MS analysis was performed using Applied Biosystem
4800 Proteomic analyzer. Mass spectra data were submitted to
the Mascot search engine (Matrix Science Ltd, London, UK) for
protein identiﬁcation against Rattus entries in the NCBI database
(accessed on 15 Nov 2012). Proteins were considered positively
identiﬁed as described by Delahunty and Yates (2005).
Competitive Enzyme-linked Immunosorbent
Assay (ELISA)
Decreased expression of alpha-2-HS glycoprotein (AHS) was
validated using a modiﬁed version of the competitive ELISA as
previously described (Mu et al., 2013). Serum samples (n = 6 for
each group; pre-treatment, days 1, 7, 14, 21, and 28) were diluted
with 0.05 M sodium bicarbonate buﬀer (pH 9.6) and loaded into
microtiter plates (Nunc, Denmark) for overnight coating of wells
at 4◦C. Plates were washed three times with 100 μl of PBST
(phosphate-buﬀered saline [PBS] with 0.05% [v/v] Tween-20),
and the wells were subsequently blocked with 100 μl of 0.5%
gelatin in PBST for 30 min at room temperature. After blocking,
the plates were washed with PBST and then incubated with goat
anti-rat AHS (1:1,000 in PBST) for 1 h at room temperature
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). Positive
controls were prepared without serum, and blanks contained
washing buﬀer. After incubation, the wells were washed with
PBST, and 200 μl of horseradish peroxidase (HRP)-labeled
secondary anti-goat IgG (1:5,000) was added to each well. The
plate was then incubated for 1 h at room temperature, followed
by washing with PBST. 100 μl of 3,3′,5,5′-tetramethylbenzidine
substrate (Sigma–Aldrich Company, St. Louis, MO, USA) was
added to eachwell and the plate was incubated for 15min at room
temperature in the dark, followed by reaction termination (100μl
2 M sulphuric acid per well). Absorbance was read at 450 nm
using an ELISA plate reader. The amount of AHSwas determined
by the percentage inhibition of substrate hydrolysis as described
previously (Reddington et al., 1991).
Results
Determination of Serum Protein Concentration
The concentrations of serum protein samples were determined
using a protein estimation kit. Estimation of the protein
concentration was based on the preparation of several dilutions
of BSA as the standard. All samples have protein concentration
with variation not more than 25% (Table 1), which indicated that
their protein amounts were almost equal.
2-DE Profile of Rat Serum Samples
Serum proteins from the pre-treatment and treated (days 1, 7, 14,
21, and 28) rat groups were separated by 2-DE on the basis of their
isoelectric points (pIs) and molecular weights, yielding complex
protein proﬁles consisting of hundreds of highly-resolved protein
TABLE 1 | Concentration of protein in serum samples.
Serum samples (Day) Concentration of serum protein (µg/µl)
Pre-treatment 52.918 ± 14.554
1 61.665 ± 40.647
7 66.250 ± 31.134
14 50.415 ± 22.827
21 75.418 ± 28.199
28 64.168 ± 30.138
All values were expressed as mean ± SD; n = 6.
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spots. Figure 2 illustrates representative serum protein proﬁles of
rats before and after treatment with E. longifolia extract.
Image Analysis of Rat Serum Proteins
Image analysis was performed on the silver-stained 2-DE gels
obtained from each serum sample of pre-treatment and extract-
treated rats. Notably, expression of most of the detected proteins
was comparable with the exception of a protein cluster designated
AHS. Protein spots corresponding to AHS were present in pre-
treatment sera but were barely visible in treated samples. Table 2
displays the average percentage of volume contribution of AHS
detected in pre-treatment sera.
FIGURE 2 | Typical 2-DE profiles of rat serum samples. (A–F) of section I
illustrate representative 2-DE profiles of rat serum from pre-treatment and
days 1, 7, 14, 21, and 28, respectively. The boxed protein cluster corresponds
to AHS, which was lost in the serum samples from rats treated with
E. longifolia extract (section II displays cropped images). Gel acidity and
relative molecular weights are indicated.
TABLE 2 | Mean percentage of volume contribution of AHS in
pre-treatment sera.
Serum protein Mean % Vol ± SD p∗
AHS 0.705 ± 0.183 0.00025
∗denotes significant value relative to the expression of days 1, 7, 14, 21, and 28,
respectively.
Identification of the Differentially Expressed
Rat Serum Protein
Analysis of the diﬀerential protein cluster with MALDI-TOF
MS/MS revealed more than twenty peaks with diﬀerent m/z, and
submission of the MS data to the Mascot search engine allowed
conﬁdent identiﬁcation of AHS. Table 3 shows the data for mass
spectrometric identiﬁcation of AHS after searching the NCBI
database.
Competitive ELISA
To validate AHS reduction upon extract treatment, competitive
ELISA was performed on the serum samples (n = 6 for each
group; pre-treatment, days 1, 7, 14, 21, and 28) using polyclonal
antisera against AHS. We observed that AHS expression was
signiﬁcantly higher in pre-treatment sera compared to post-
treatment sera (Figure 3).
Discussion
Here, we have analyzed serum from rats treated with
standardized E. longifolia extract by 2-DE and observed the
obvious loss of a particular protein cluster upon treatment.
TABLE 3 | Identification of the differentially expressed rat serum protein
detected on 2-DE gel.
Protein
entry
name+
Protein
name
Accession
number#
Nominal
mass
(kDa)/pI
MOWSE
protein
score
Sequence
coverage (%)
AHS Alpha-2-HS
glycoprotein
gi|6978477 38/6.30 64 9
(a) + Protein entry name is from the UniProtKB database.
(b) # Accession number is from the NCBI database using Mascot search engine
(accessed on 15 Nov 2012).
FIGURE 3 | Mean percentage of inhibition of AHS in the pre-treatment
and post-treatment serum samples. Analysis was performed by
competitive ELISA. AHS concentrations in the pre-treatment sera were
significantly higher than those in the post-treatment samples (days 1, 7, 14,
21, and 28). The amount of AHS present was proportional to the percentage
inhibition of substrate hydrolysis. Asterisk denotes statistical significance
(p < 0.05) of post-treatment samples compared to that of pre-treatment
sample (n = 6).
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Subsequently, we identiﬁed this protein cluster to be AHS,
which could be seen in sera from untreated rats but was hardly
detectable in sera from rats treated with standardized E. longifolia
extract for 1–28 days. Finally, we conﬁrmed the extract-induced
reduction in AHS using competitive ELISA.
Alpha-2-HS glycoprotein, also known as alpha2-Heremans-
Schmid glycoprotein or fetuin A, is a serum protein that
participates in bone metabolism since it is one of the major
components of non-collagenous bone matrix (Dickson et al.,
1975). It accumulates in the skeleton due to its high aﬃnity
for hydroxyapatite. Also, several reports have suggested that
AHS is involved in host defense, particularly in phagocytosis
and innate immunity (Arnaud et al., 1988). Indeed, AHS is a
negative acute phase protein and its concentration decreases
during infection.
In addition, AHS has been linked to insulin resistance
and diabetes (Stefan et al., 2006). The insulin receptor is a
disulﬁde-linked heterotetrameric protein complex consisting of
two hormone-binding α subunits and two signaling β subunits
containing tyrosine kinase activity (Srinivas et al., 1993). Insulin
binds to this receptor located on the surface of insulin responsive
cells, leading to the activation of the tyrosine kinase and
subsequently the autophosphorylation of β subunit in order
to activate the function of insulin toward the physiological
function (Myers and White, 1996). The phosphorylated form
of AHS acts as a natural competitve inhibitor of insulin,
which blocks both activities, potentially contributing to the
development of type-2 diabetes (Srinivas et al., 1993). It was also
reported that testosterone levels correlated positively with insulin
sensitivity (Pitteloud et al., 2005). Thus, testosterone, which can
be produced in response to insulin, is a modulator of insulin
sensitivity. Therefore, we propose that the quassinoid-containing
E. longifolia extract aﬀects male infertility by suppressing AHS
expression, which indirectly increases insulin sensitivity and
testosterone levels in accordance with our previous ﬁndings (Low
et al., 2013). Our earlier study showed that the testosterone
enhancement activity of E. longifolia has been prolonged in
the treated rats after the 28 days treatment of E. longifolia
extract when they had displayed signiﬁcantly higher sperm
count (P < 0.001) than that of the untreated control (Low
et al., 2013). In addition, the present ﬁnding also proposed
that the E. longifolia extract could be used as a supplement
to prevent insulin resistance by modulating phosphorylated
AHS, which is present in healthy individuals (Haglund et al.,
2001).
Taken together, our ﬁndings indicate that serum AHS was
reduced in rats treated with standardized E. longifolia extract,
and provide rational for further investigation into the eﬀects of
this natural extract in animal models involving infertility and
diabetes.
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